HariharanSubramanianMD
Cardiology • Holyoke, MAAdult Congenital Heart Disease, Cardiac Electrophysiology, Heart Failure & Transplantation
Physician
Are you Dr. Subramanian?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 41 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
575 Beech St
1st Floor
Holyoke, MA 01040Phone+1 413-534-2870
Summary
- Dr. Hariharan Subramanian, MD is a cardiologist in Holyoke, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Connecticut, and Pennsylvania. He is affiliated with Holyoke Medical Center and Baystate Medical Center.
Education & Training
Drexel University College of Medicine/Hahnemann University HospitalFellowship, Cardiovascular Disease, 2011 - 2014
Abington Memorial HospitalResidency, Internal Medicine, 2004 - 2007
Kilpauk Medical CollegeClass of 2000
Certifications & Licensure
MA State Medical License 2014 - 2025
PA State Medical License 2004 - 2014
CT State Medical License 2008 - 2012- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Gene therapy with phosphodiesterases 2A and 4B ameliorates heart failure and arrhythmias by improving subcellular cAMP compartmentation.Nikoleta Pavlaki, Alexander Froese, Wener Li, Kirstie A De Jong, Birgit Geertz
Cardiovascular Research. 2024-07-31 - AKAP12 Overexpression Affects Cardiac Function via PDE8.Hariharan Subramanian, Viacheslav O Nikolaev
Circulation Research. 2024-04-12 - 3 citationsRemodelling of cAMP dynamics within the SERCA2a microdomain in heart failure with preserved ejection fraction caused by obesity and type 2 diabetes.Ping Lai, Susanne S Hille, Hariharan Subramanian, Robert Wiegmann, Pia Roser
Cardiovascular Research. 2024-03-14
Press Mentions
- Invariant Natural Killer T Cells in Hematopoietic Stem Cell Transplantation: Killer Choice for Natural SuppressionFebruary 15th, 2020
Professional Memberships
- Member
